JPWO2020168291A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020168291A5 JPWO2020168291A5 JP2021547336A JP2021547336A JPWO2020168291A5 JP WO2020168291 A5 JPWO2020168291 A5 JP WO2020168291A5 JP 2021547336 A JP2021547336 A JP 2021547336A JP 2021547336 A JP2021547336 A JP 2021547336A JP WO2020168291 A5 JPWO2020168291 A5 JP WO2020168291A5
- Authority
- JP
- Japan
- Prior art keywords
- ribonucleic acid
- sequence
- engineered
- engineered nuclease
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023146414A JP7502537B2 (ja) | 2019-02-14 | 2023-09-08 | Ｒｕｖｃドメインを有する酵素 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962805899P | 2019-02-14 | 2019-02-14 | |
| US201962805868P | 2019-02-14 | 2019-02-14 | |
| US201962805878P | 2019-02-14 | 2019-02-14 | |
| US62/805,868 | 2019-02-14 | ||
| US62/805,899 | 2019-02-14 | ||
| US62/805,878 | 2019-02-14 | ||
| US201962874414P | 2019-07-15 | 2019-07-15 | |
| US62/874,414 | 2019-07-15 | ||
| PCT/US2020/018432 WO2020168291A1 (en) | 2019-02-14 | 2020-02-14 | Enzymes with ruvc domains |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023146414A Division JP7502537B2 (ja) | 2019-02-14 | 2023-09-08 | Ｒｕｖｃドメインを有する酵素 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022520428A JP2022520428A (ja) | 2022-03-30 |
| JPWO2020168291A5 true JPWO2020168291A5 (ko) | 2023-02-21 |
Family
ID=72045639
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547336A Ceased JP2022520428A (ja) | 2019-02-14 | 2020-02-14 | Ｒｕｖｃドメインを有する酵素 |
| JP2023146414A Active JP7502537B2 (ja) | 2019-02-14 | 2023-09-08 | Ｒｕｖｃドメインを有する酵素 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023146414A Active JP7502537B2 (ja) | 2019-02-14 | 2023-09-08 | Ｒｕｖｃドメインを有する酵素 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240117330A1 (ko) |
| EP (1) | EP3924482A4 (ko) |
| JP (2) | JP2022520428A (ko) |
| KR (2) | KR20240007322A (ko) |
| CN (2) | CN113728098A (ko) |
| AU (2) | AU2020223370B2 (ko) |
| CA (1) | CA3130135A1 (ko) |
| MX (2) | MX2021009886A (ko) |
| WO (1) | WO2020168291A1 (ko) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3130135A1 (en) | 2019-02-14 | 2020-08-20 | Metagenomi Ip Technologies, Llc | Enzymes with ruvc domains |
| US10913941B2 (en) | 2019-02-14 | 2021-02-09 | Metagenomi Ip Technologies, Llc | Enzymes with RuvC domains |
| GB2594339B (en) * | 2020-02-14 | 2023-02-08 | Metagenomi Inc | Enzymes with RUVC domains |
| EP4114932A4 (en) | 2020-03-06 | 2024-03-13 | Metagenomi, Inc. | CLASS II, TYPE V CRISPR SYSTEMS |
| MX2022012110A (es) * | 2020-03-31 | 2022-10-18 | Metagenomi Inc | Sistemas crispr clase ii tipo ii. |
| WO2022056301A1 (en) * | 2020-09-11 | 2022-03-17 | Metagenomi Ip Technologies, Llc | Base editing enzymes |
| WO2022098681A2 (en) * | 2020-11-03 | 2022-05-12 | Caspr Biotech Corporation | Novel class 2 crispr-cas rna-guided endonucleases |
| KR20230134543A (ko) * | 2021-01-22 | 2023-09-21 | 메타지노미, 인크. | 신규한 조작된 뉴클레아제 및 키메라 뉴클레아제 |
| WO2022159742A1 (en) * | 2021-01-22 | 2022-07-28 | Metagenomi, Inc | Novel engineered and chimeric nucleases |
| WO2022232638A2 (en) * | 2021-04-30 | 2022-11-03 | Metagenomi, Inc. | Enzymes with ruvc domains |
| WO2023122663A2 (en) * | 2021-12-23 | 2023-06-29 | Mammoth Biosciences, Inc. | Effector proteins and methods of use |
| WO2023194359A1 (en) * | 2022-04-04 | 2023-10-12 | Alia Therapeutics Srl | Compositions and methods for treatment of usher syndrome type 2a |
| WO2023245141A2 (en) * | 2022-06-15 | 2023-12-21 | Beam Therapeutics Inc. | Compositions and methods for reducing complement activation |
| WO2024056880A2 (en) * | 2022-09-16 | 2024-03-21 | Alia Therapeutics Srl | Enqp type ii cas proteins and applications thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201912327SA (en) * | 2012-12-12 | 2020-02-27 | Broad Inst Inc | Engineering and Optimization of Improved Systems, Methods and Enzyme Compositions for Sequence Manipulation |
| US10392607B2 (en) * | 2015-06-03 | 2019-08-27 | The Regents Of The University Of California | Cas9 variants and methods of use thereof |
| WO2016205759A1 (en) * | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation |
| WO2018035250A1 (en) * | 2016-08-17 | 2018-02-22 | The Broad Institute, Inc. | Methods for identifying class 2 crispr-cas systems |
| CN112020554A (zh) * | 2018-02-23 | 2020-12-01 | 先锋国际良种公司 | 新颖cas9直系同源物 |
| CA3130135A1 (en) | 2019-02-14 | 2020-08-20 | Metagenomi Ip Technologies, Llc | Enzymes with ruvc domains |
-
2020
- 2020-02-14 CA CA3130135A patent/CA3130135A1/en active Pending
- 2020-02-14 JP JP2021547336A patent/JP2022520428A/ja not_active Ceased
- 2020-02-14 CN CN202080028787.6A patent/CN113728098A/zh active Pending
- 2020-02-14 MX MX2021009886A patent/MX2021009886A/es unknown
- 2020-02-14 KR KR1020247000311A patent/KR20240007322A/ko active Search and Examination
- 2020-02-14 EP EP20756259.6A patent/EP3924482A4/en active Pending
- 2020-02-14 WO PCT/US2020/018432 patent/WO2020168291A1/en unknown
- 2020-02-14 AU AU2020223370A patent/AU2020223370B2/en active Active
- 2020-02-14 KR KR1020217028874A patent/KR102623312B1/ko active IP Right Grant
- 2020-02-14 CN CN202310441977.6A patent/CN116515797A/zh active Pending
-
2021
- 2021-08-16 MX MX2023006575A patent/MX2023006575A/es unknown
-
2023
- 2023-06-15 US US18/335,481 patent/US20240117330A1/en active Pending
- 2023-07-17 AU AU2023206079A patent/AU2023206079A1/en active Pending
- 2023-09-08 JP JP2023146414A patent/JP7502537B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020168291A5 (ko) | ||
| CN111836894B (zh) | 用于使用CRISPR/Cpf1系统进行基因组编辑的组合物及其用途 | |
| JP2019524149A5 (ko) | ||
| JP2021121205A5 (ko) | ||
| US20150291961A1 (en) | RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX | |
| JP2020506667A5 (ko) | ||
| RU2015128102A (ru) | Компоненты системы crispr-cas, способы и композиции для манипуляции с последовательностями | |
| JP2016537028A5 (ko) | ||
| JP2018518182A5 (ko) | ||
| Emadzade et al. | Differential amplification of satellite PaB6 in chromosomally hypervariable Prospero autumnale complex (Hyacinthaceae) | |
| AU2016308283A1 (en) | Capture of nucleic acids using a nucleic acid-guided nuclease-based system | |
| JP2018537955A5 (ko) | ||
| JP2018534950A5 (ko) | ||
| IL288263B (en) | CRISPR DNA/RNA hybrid polynucleotides and methods of using them | |
| CN107532210A (zh) | Dna合成的方法 | |
| JP2012525849A5 (ko) | ||
| JP2016502858A5 (ko) | ||
| JP2015536680A (ja) | 分子の作製 | |
| RU2022103641A (ru) | Искусственная модификация генома для регуляции экспрессии гена | |
| GB2605340A (en) | Base editing enzymes | |
| JP2020536506A5 (ko) | ||
| FI4025691T3 (fi) | Uusia, luonnossa esiintymättömiä CRISPR-CAS-nukleaaseja genomin muokkausta varten | |
| GB2608292A (en) | Class II, type II CRISPR systems | |
| JPWO2021178933A5 (ko) | ||
| CN105602972B (zh) | 基于CRISPR-Cas9体外改造腺病毒载体的方法 |